Globe News Wire
16 Nov 2026, 06:30 UTC · 19h ago
Lakefront start nieuw aandeleninkoopprogramma ter waarde van €50 miljoen na voltooiing van initieel aandeleninkoopprogramma
Impact · against what's priced in
Lakefront Biotherapeutics is initiating a second consecutive €50 million share buyback program. This demonstrates strong capital allocation and cash reserves, providing a positive catalyst for earnings per share and share price support.
- LKFT+0.40
No priced-in read yet





